Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

GPs Meet Rare Lung Disorders Task Force factsheet: primary ciliary dyskinesia

Fernando M. de Benedictis
Breathe 2015 11: 159-161; DOI: 10.1183/20734735.112215
Fernando M. de Benedictis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pediatria@fmdebenedictis.it
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Definition

Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease of abnormalities of ciliary structure and function. The result is impaired mucociliary clearance, causing a variety of respiratory symptoms, and likely progression to bronchiectasis in most cases. Situs anomalies are present in nearly 50% of cases.

Prevalence

The prevalence of PCD is thought to be around l in 10,000-15,000, but is very difficult to estimate accurately. This is due partly to difficulties in making the diagnosis, as a consequence of the large variation in clinical phenotype.

Clinical manifestations

Children with PCD often have a clinical history oflower airway disease, manifested in a chronic wet-sounding cough and, occasionally, wheeze or shortness of breath. In addition, virtually all subjects show evidence of chronic upper airway symptoms, such as chronic rhinitis (nasal discharge, episodic facial pain and anosmia). Ear symptoms (recurrent otitis media and glue ear) are a frequent complication that can require repeated courses of antibiotics. In table 1, the clinical aspects of PCD are displayed by various age groups. PCD is likely to include a small number of milder phenotypes that may be manifest in subtle or no apparent structural defects and ciliary dysfunction small number of milder phenotypes that may be manifest in subtle or no apparent structural defects and ciliary dysfunction

View this table:
  • View inline
  • View popup
Table 1.

Symptoms and findings of PCD according to age group

Diagnosis

The diagnosis of PCD requires the presence of the characteristic clinical phenotype and either specific ultra structural ciliary defects identified by transmission electron microscopy or evidence of abnormal ciliary function. Screening tests (nasal nitric oxide measurement, saccarin test) may precede formal ciliary function analysis, thereby reducing the number of referrals for ciliary analysis. A positive family history of PCD is an indication for performing diagnostics. Siblings of probands should also have PCD excluded.

Several genes have been identified to date for autosomal recessive PCD variants. Genetic analyses may help to assess the carrier status of family members and provide tools for informed reproductive choices, although this is currently possible only for a minority of families. They may also become more important diagnostically since about 35% of PCD patients carry gene mutations.

Referral

Diagnosis should be confirmed in a specialist centre, as diagnostic analysis and interpretation are difficult.

Treatment and follow-up

As with all chronic respiratory diseases, the aim of therapy for PCD is to restore or maintain normal lung function as far as is possible, based on early detection and vigorous treatment of complications.Management of PCD involves aggressive treatment of upper and lower airway infections by antibiotics, and airway clearance by combinations of physiotherapy and physical exercise.

By analogy with cystic fibrosis (CF), PCD patients should be managed in specialised centres, in which they have regular access to respiratory paediatricians, audiology, ENT surgeons and respiratory physiotherapists.

Key messages

  • Presentation in PCD is often non-specific, or has features typical of many childhood illnesses

  • Think about PCD if your patient has chronic symptoms of both upper and lower airway infection and situs inversus viscerum

  • PCD is an important cause of progressive lung disease and our key aim is to establish an early diagnosis and institute treatment strategies prior to the onset of irreversible lung damage.

  • Refer the patient to a centre with experience in performing ultrastructural and functional studies of cilia

  • Follow your patient in collaboration with the reference centre

Case report

A 7-year-old boy was referred to a paediatric outpatient clinic for asthma resistant to treatment. He had a history of nasal obstruction with chronic mucopurulent discharge and chronic cough since the first months of life. He also presented with recurrent episodes of otitis media with secretion during infancy and two episodes of pneumonia during his preschool years. No overt episodes of wheezing were described. At the age of 6 years, a skin prick test showed positivity to house dust mites and alternaria. The diagnosis of allergic rhinitis and asthma was made, and treatment with inhaled corticosteroids and antihistamines was given for months, with no success.

At physical examination, situs inversus viscerum with dextrocardia was revealed. Spirometry was normal. Electron microscopy revealed ultrastructural ciliary defects in 100% of cilia obtained by nasal brushing. The diagnosis of primary cilia dyskinesia was made and proper management was planned.

  • ©ERS 2015

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Further reading

    1. Barbato A,
    2. Frisher T,
    3. Kuehni CE, et al.
    Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Resp J 2009; 34: 1264–1276.
    OpenUrlAbstract/FREE Full Text
    1. Strippoli MP,
    2. Frischer T,
    3. Barbato A, et al.
    ERS Task Force on Primary Ciliary Dyskinesia in Children. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J 2012; 39: 1482–1491.
    OpenUrlAbstract/FREE Full Text
  1. www.pcdfoundation.org. The foundation of Primary Ciliary Diskinesia syndrome.
  2. www.orpha.net. The portal for Rare Diseases and orphan drugs.
PreviousNext
Back to top
Vol 11 Issue 2 Table of Contents
Breathe: 11 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
GPs Meet Rare Lung Disorders Task Force factsheet: primary ciliary dyskinesia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
GPs Meet Rare Lung Disorders Task Force factsheet: primary ciliary dyskinesia
Fernando M. de Benedictis
Breathe Jun 2015, 11 (2) 159-161; DOI: 10.1183/20734735.112215

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
GPs Meet Rare Lung Disorders Task Force factsheet: primary ciliary dyskinesia
Fernando M. de Benedictis
Breathe Jun 2015, 11 (2) 159-161; DOI: 10.1183/20734735.112215
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Definition
    • Prevalence
    • Clinical manifestations
    • Diagnosis
    • Referral
    • Treatment and follow-up
    • Further reading
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society